Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Dragojlovic

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Aging Studies|April 9, 2013
Canadians' support for radical life extension resulting from advances in regenerative medicineNick Dragojlovic
Drug Discovery Today|July 17, 2016
What will the crowd fund? Preferences of prospective donors for drug development fundraising campaignsNick Dragojlovic, Larry D Lynd
Drug Discovery Today|June 29, 2014
Crowdfunding drug development: the state of play in oncology and rare diseasesNick Dragojlovic, Larry D Lynd
International Journal of Technology Assessment in Health Care|July 21, 2025
On the potential value of eHTA: a commentary on "Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique"Nick Dragojlovic, Mark Harrison, Larry David Lynd
Journal of Community Genetics|July 6, 2019
Allocating healthcare resources to genomic testing in Canada: latest evidence and current challengesDeirdre Weymann, Nick Dragojlovic, Samantha Pollard, et al.
Journal of Genetic Counseling|April 10, 2019
Genetic counseling considerations with rapid genome-wide sequencing in a neonatal intensive care unitEmma E Smith, Christèle du Souich, Nick Dragojlovic, et al.
Pharmacoeconomics|November 5, 2020
Evaluating New Zealanders' Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common ConditionsLinda Yamoah, Nick Dragojlovic, Alesha Smith, et al.
Clinical Therapeutics|July 29, 2023
Defining Need Amid Exponential Change: Conceptual Challenges in Workforce Planning for Clinical Genetic ServicesKennedy Borle, Nicola Kopac, Nick Dragojlovic, et al.
Pharmacoeconomics|June 20, 2025
Innovation Headroom for a Highly Accurate PD-L1 Companion Diagnostic in Non-small Cell Lung CancerToluwase Akinsoji, Nick Dragojlovic, Cécile Darviot, et al.
Journal of Evaluation in Clinical Practice|April 1, 2018
Evaluating the use of parental reports to estimate health care resource utilization in children with suspected genetic disordersNick Dragojlovic, Ellen Kim, Alison M Elliott, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Aging Studies|April 9, 2013
Canadians' support for radical life extension resulting from advances in regenerative medicineNick Dragojlovic
Drug Discovery Today|July 17, 2016
What will the crowd fund? Preferences of prospective donors for drug development fundraising campaignsNick Dragojlovic, Larry D Lynd
Drug Discovery Today|June 29, 2014
Crowdfunding drug development: the state of play in oncology and rare diseasesNick Dragojlovic, Larry D Lynd
International Journal of Technology Assessment in Health Care|July 21, 2025
On the potential value of eHTA: a commentary on "Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique"Nick Dragojlovic, Mark Harrison, Larry David Lynd
Journal of Community Genetics|July 6, 2019
Allocating healthcare resources to genomic testing in Canada: latest evidence and current challengesDeirdre Weymann, Nick Dragojlovic, Samantha Pollard, et al.
Journal of Genetic Counseling|April 10, 2019
Genetic counseling considerations with rapid genome-wide sequencing in a neonatal intensive care unitEmma E Smith, Christèle du Souich, Nick Dragojlovic, et al.
Pharmacoeconomics|November 5, 2020
Evaluating New Zealanders' Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common ConditionsLinda Yamoah, Nick Dragojlovic, Alesha Smith, et al.
Clinical Therapeutics|July 29, 2023
Defining Need Amid Exponential Change: Conceptual Challenges in Workforce Planning for Clinical Genetic ServicesKennedy Borle, Nicola Kopac, Nick Dragojlovic, et al.
Pharmacoeconomics|June 20, 2025
Innovation Headroom for a Highly Accurate PD-L1 Companion Diagnostic in Non-small Cell Lung CancerToluwase Akinsoji, Nick Dragojlovic, Cécile Darviot, et al.
Journal of Evaluation in Clinical Practice|April 1, 2018
Evaluating the use of parental reports to estimate health care resource utilization in children with suspected genetic disordersNick Dragojlovic, Ellen Kim, Alison M Elliott, et al.
Pageof 3